The overall aim of the study is to compare the effects of three types of beverages - sugar-sweetened (SSB), artificially sweetened (ASB), and unsweetened (USB) - on cardiovascular disease (CVD) risk factors and body weight among young adults.
Consumption of sugar sweetened beverages (SSB) has been linked to obesity and, independent of body weight, risk for diabetes and cardiovascular disease. With rising public health awareness of these potential adverse effects, consumption of artificially sweetened beverages (ASB) has increased dramatically. These low-calorie products are marketed as "diet," with the implication that they promote weight loss and improved health. However, there are no long-term experimental studies of ASB and body weight or any other health outcome. Several recent prospective observational studies have linked intake of ASB to increased risk of the metabolic syndrome, type 2 diabetes, and obesity. In the proposed clinical trial, 270 young adults who habitually consume SSB will be randomly assigned to one of three groups: 1) to continue consuming habitual levels of SSB; 2) to substitute ASB for SSB; or 3) to substitute unsweetened beverages for SSB. Each group will receive home delivery of the targeted beverage for 1 year, using methods that build upon previous successful work. Careful attention will be given to assuring treatment fidelity, equivalence of treatment intensity, and avoidance of experimental confounders. The primary study endpoint will be the ratio of serum triglyceride to HDL-cholesterol concentrations. Secondary endpoints will include changes in other cardiovascular disease risk factors, body weight, dietary quality, and taste preferences.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
203
Home delivery of specified beverage type
Children's Hospital Boston
Boston, Massachusetts, United States
Ratio of Serum Triglyceride to HDL-cholesterol Concentration (TG:HDLC)
Time frame: 12 Month
LDL-C
LDL-C
Time frame: 12 Month
hsCRP
hsCRP
Time frame: 12 Month
Fibrinogen
Fibrinogen
Time frame: 12 Month
Uric Acid
Uric Acid
Time frame: 12 Month
ALT
ALT
Time frame: 12 Month
Systolic Blood Pressure
Systolic Blood Pressure
Time frame: 12 Month
Diastolic Blood Pressure
Diastolic Blood Pressure
Time frame: 12 Month
Body Weight
Body Weight
Time frame: 12 Month
Diet Quality: Sugar-Sweetened Beverage Consumption
Diet Quality: Sugar-Sweetened Beverage Consumption - servings per day
Time frame: 12 Month
Preference for Sweet Taste
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
We evaluated preference for sweet taste using ten solutions ranging in sucrose concentration (%m/v) from 0% (sample 1) to 18% (sample 10). After tasting each solution, participant reported the sample number corresponding to his or her overall favorite.
Time frame: 12 Month